Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.24.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Revenues $ 2,140,726 $ 2,507,794
FC2 [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 2,140,726 2,500,001
FC2, Global Public Health Sector [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 1,507,007 2,336,997
FC2, U.S. Prescription Channel [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 633,719 163,004
ENTADFI [Member]    
Disaggregation of Revenue [Line Items]    
Revenues   $ 7,793